T2 Biosystems amends loan terms, extends maturity date
Inc., a company specializing in medical instruments and apparatus, has entered into a significant amendment to its existing ...
T2 Biosystems reports preliminary Q4 revenue $2.3M
We made considerable progress across the business during 2024, increasing our global installed base of T2Dx Instruments, and generating record ...
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
Achieved record fourth quarter and full-year 2024 sepsis product revenuesLEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ...
T2 Biosystems Reports Preliminary Financial Results For Q4 And Full Year 2024
T2 Biosystems, Inc. (TTOO), a Massachusetts-based biotechnology company, on Tuesday reported its preliminary financial and ...